EMD-25574

Single-particle
2.69 Å
EMD-25574
3D View Gallery
Deposition: 29/11/2021
Map released: 13/04/2022
Last modified: 13/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-25574

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-7t01 summary report (pdf.gz) Map-7t01 FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

SARS-CoV-2 S-RBD + Fab 54042-4

EMD-25574

Single-particle
2.69 Å
EMD-25574
3D View Gallery
Deposition: 29/11/2021
Map released: 13/04/2022
Last modified: 13/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Sample: Complex of SARS-CoV-2 S-ECD with 54042-4 Fab
Fitted models: 7t01

Deposition Authors: Johnson NV , Mclellan JS
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition.
Kramer KJ, Johnson NV , Shiakolas AR , Suryadevara N , Periasamy S, Raju N, Williams JK, Wrapp D , Zost SJ , Walker LM, Wall SC, Holt CM, Hsieh CL, Sutton RE, Paulo A, Nargi RS, Davidson E, Doranz BJ, Crowe Jr JE, Bukreyev A, Carnahan RH, McLellan JS , Georgiev IS
(2021) Cell Rep , 37 , 109784 - 109784
PUBMED: 34592170
DOI: doi:10.1016/j.celrep.2021.109784
ISSN: 2211-1247